The first Kindred Biosciences trade was made in Q1 2014.
Since then Ken Griffin bought shares six more times and sold shares on seven occasions. The investor completely sold their stake between Q1 2021 and Q3 2021.
Avg closing price
Price range
Sold -16.4 Thousand shares
Q3 2021
Avg closing price
$9.19
Price range
$9.08
-
$9.25
Sold 74.4% shares (-47.7 Thousand shares)
Q2 2021
Avg closing price
$5.82
Price range
$4.22
-
$9.23
Sold 17.4% shares (-13.5 Thousand shares)
Q1 2021
Avg closing price
$4.83
Price range
$4.39
-
$5.39
Increased shares by 97.5% (+38.3 Thousand shares)
Q3 2020
Avg closing price
$4.18
Price range
$3.29
-
$5.29
Increased shares by 69.8% (+16.2 Thousand shares)
Q2 2020
Avg closing price
$4.47
Price range
$3.45
-
$5.30
New holding (+23.1 Thousand shares)
Q1 2020
Avg closing price
$8.49
Price range
$3.26
-
$11.01
Sold -13.5 Thousand shares
Q1 2019
Avg closing price
$10.16
Price range
$8.27
-
$11.87
Sold 49.7% shares (-13.3 Thousand shares)
Q4 2018
Avg closing price
$12.60
Price range
$10.57
-
$14.85
Increased shares by 30.5% (+6.24 Thousand shares)
Q3 2018